Navigation Links
NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Date:10/30/2009

SAN MATEO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Friday, November 6, 2009 at 9:00 a.m. ET (6:00 a.m. PT) to report results for its third quarter 2009.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning November 6, 2009 at 7:30 p.m. ET (4:30 p.m. PT) and ending on November 16, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 336156. A replay of the webcast will also be available on the corporate website for one month, through December 6, 2009.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatmen
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX to Present at JMP Securities Healthcare Focus Conference
2. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
3. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
4. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
5. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
6. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
7. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Missouri. The ... (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 19,030 boxes of medicine ...
(Date:8/20/2014)... , Aug. 20, 2014 PTC Therapeutics, Inc. (NASDAQ: ... two upcoming investor conferences: - FBR 1 st ... Boston on Wednesday, September 3 rd ... The Mandarin Oriental Boston on Thursday, September 4 th ... update at the Bank of America Merrill Lynch Global Healthcare ...
Breaking Medicine Technology:Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2PTC Therapeutics to Participate at Upcoming Investor Conferences 2
... CINCINNATI, Jan. 12, 2012   Prasco® Laboratories announced today ... (NASDAQ: SHPGY ) for the distribution ...   version of Carbatrol® (Carbamazepine) Extended-Release Capsules in 100 ... Carbamazepine Extended-Release Capsules are AB-rated, therapeutically equivalent and ...
...   Optimer Pharmaceuticals, Inc. (NASDAQ: ... Ph.D., Chief Operating Officer & Senior Vice President, ... other interests. (Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ... been a great experience building Optimer Pharmaceuticals and bringing ...
Cached Medicine Technology:Prasco® Launches Authorized Generic of Shire's Carbatrol® 2Prasco® Launches Authorized Generic of Shire's Carbatrol® 3Prasco® Launches Authorized Generic of Shire's Carbatrol® 4Chief Operating Officer Tessie M. Che Departing Company 2Chief Operating Officer Tessie M. Che Departing Company 3
(Date:8/20/2014)... Recently, UWDress.com, the distinguished wedding dress manufacturer and ... party dresses for girls . According to the company’s ... handmade by experienced specialists. Now, they are provided with ... company’s new items come in various styles: A-line scalloped ... long elegant backless gowns and so on. It is ...
(Date:8/20/2014)... An Elle Magazine online report dated August ... Looking Young at Every Age,” offers a set of recommendations ... . These recommendations are offered as a preventative skincare ... 25-45 and beyond. The first group of recommendations can be ... includes using sunscreen religiously, getting sufficient exercise and sleep, and ...
(Date:8/20/2014)... August 20, 2014 Today, Zane ... the publication of a new eBook, Affordable Care ... small business owners feel uncertain about how the ... and their bottom line. , The new eBook ... helps businesses navigate their upcoming health insurance decisions. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Ticket Down ... tickets in NYC. In just a week, the U.S. ... King Tennis Center. The event was originally founded in 1881 and ... Rafael Nadal was forced to withdrawal from the event because of ... women’s tournament and will return to New York City with hopes ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... experimental drug has saved a group of rhesus monkeys from ... that kills up to 90 percent of those it infects, ... lethal doses of Marburg virus, even when it was given ... 20 in the journal Science Translational Medicine . ...
Breaking Medicine News(10 mins):Health News:Cheap Birthday Party Dresses for Girls Now Available at UWDress.com 2Health News:Simon Ourian, Kim Kardashian’s Doctor, On Healthy Skin Suggestions for Every Age 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3
... fill gaps and offset rising employee-paid healthcare costs. , ... ... employers have completed their annual benefit enrollment period, Combined Insurance ... insurance benefits and coverage to identify potential gaps in coverage due ...
... , ... Cincinnati, OH (PRWEB) February ... an innovative solution to a pressing health care concern – ... medication therapy., , ,This concern was underscored in a recent ...
... Raw Materials CatalogST. LOUIS, Feb. 10 SAFC Supply ... the Sigma-Aldrich Group (Nasdaq: SIAL ) ... today announced that it has added 50 new Certified ... materials product line. Details of the new products ...
... rBGH milk from Yoplait Yogurt."SAN FRANCISCO, Feb. 9 ... watchdog of the breast cancer movement - today ... General Mills remove the cancer-linked synthetic growth hormone, ... of BCA,s 2008 "Think Before You Pink" campaign ...
... Publish Study Defining Mechanism,and Potential Treatment for Rett Syndrome, ... Clinical trial to test molecule in humans is being ... apply to other forms of autism - , BOSTON ... innovative research, clinical and family collaboration dedicated to radically ...
... Feb. 9 Ten health professional students pursuing ... and $2,000 scholarships from the National Hispanic Health ... Professional Student Scholarship Gala at the Sheraton Grand ... keynote speaker will be the Honorable Dean Florez, ...
Cached Medicine News:Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 2Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 3Health News:AdherenceRx Partners with Hummingbird Coaching To Increase Patient Medication Adherence 2Health News:AdherenceRx Partners with Hummingbird Coaching To Increase Patient Medication Adherence 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 4Health News:Breast Cancer Action Victorious in Yoplait 'Pinkwashing' Campaign 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 3Health News:NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals 2
Security and confidence assured with porous tape; integral deodorizing/venting filter....
Inquire...
Inquire...
Superior Skin Care...Convex FlexWear skin barrier is secure and provides extended weartime. Security and confidence assured with internal non-reflux valves and a drain valve that allows regulation of...
Medicine Products: